Menu Search
Equities

Kooth PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
KO0:FRA

Kooth PLC

Actions
  • Price (EUR)1.59
  • Today's Change0.05 / 3.25%
  • Shares traded1.50k
  • 1 Year change-18.04%
  • Beta1.0794
Data delayed at least 15 minutes, as of Feb 06 2026 15:44 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Kooth plc is a United Kingdom-based digital mental health service provider. The Company’s platform is clinically robust and accredited to provide a range of therapeutic support and interventions. Its products include Kooth.com, Qwell.io, and Soluna platform. Kooth.com is commissioned both in the United Kingdom and the United States. In the United Kingdom, the national health service (NHS), local authorities, charities and businesses have access to anonymous and personalized mental health support for children and young people. Qwell.io is commissioned by the NHS, local authorities and charities to improve the mental health of entire populations of specific cohorts. Soluna offers youth people to access a range of services beyond mental health support, acting as a digital front door connecting users and a range of public services. Specifically designed for users aged 13-25, Soluna provides comprehensive mental health support via an app, Web-platform, and contact center.

  • Revenue in GBP (TTM)66.34m
  • Net income in GBP2.86m
  • Incorporated2020
  • Employees593.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		KOO:LSE since
announced		Transaction
value
Kismet Health Inc-Telehealth PlatformDeal completed19 Nov 202519 Nov 2025Deal completed4.71%--
Data delayed at least 20 minutes, as of Feb 06 2026 15:56 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.